Copyright Reports & Markets. All rights reserved.

Global Medical Anti-Thrombotic Coating Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Anti-Thrombotic Coating Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Thin Coating
    • 1.3.3 Thick Coating
  • 1.4 Market Analysis by Coating Method
    • 1.4.1 Overview: Global Medical Anti-Thrombotic Coating Consumption Value by Coating Method: 2021 Versus 2025 Versus 2032
    • 1.4.2 Dip-Coated Anti-Thrombotic Layer
    • 1.4.3 Spray-Coated Anti-Thrombotic Layer
    • 1.4.4 Plasma-Deposited Coating
  • 1.5 Market Analysis by Durability Profile
    • 1.5.1 Overview: Global Medical Anti-Thrombotic Coating Consumption Value by Durability Profile: 2021 Versus 2025 Versus 2032
    • 1.5.2 Short-Term Blood-Contact Coating
    • 1.5.3 Long-Term Implantable Coating
    • 1.5.4 Controlled-Degradation Coating
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Medical Anti-Thrombotic Coating Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Catheter
    • 1.6.3 Stent Delivery System
    • 1.6.4 Guide Wire
    • 1.6.5 Others
  • 1.7 Global Medical Anti-Thrombotic Coating Market Size & Forecast
    • 1.7.1 Global Medical Anti-Thrombotic Coating Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Medical Anti-Thrombotic Coating Sales Quantity (2021-2032)
    • 1.7.3 Global Medical Anti-Thrombotic Coating Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 DSM Biomedical
    • 2.1.1 DSM Biomedical Details
    • 2.1.2 DSM Biomedical Major Business
    • 2.1.3 DSM Biomedical Medical Anti-Thrombotic Coating Product and Services
    • 2.1.4 DSM Biomedical Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 DSM Biomedical Recent Developments/Updates
  • 2.2 Surmodics
    • 2.2.1 Surmodics Details
    • 2.2.2 Surmodics Major Business
    • 2.2.3 Surmodics Medical Anti-Thrombotic Coating Product and Services
    • 2.2.4 Surmodics Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Surmodics Recent Developments/Updates
  • 2.3 Specialty Coating Systems (SCS)
    • 2.3.1 Specialty Coating Systems (SCS) Details
    • 2.3.2 Specialty Coating Systems (SCS) Major Business
    • 2.3.3 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product and Services
    • 2.3.4 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Specialty Coating Systems (SCS) Recent Developments/Updates
  • 2.4 Biocoat
    • 2.4.1 Biocoat Details
    • 2.4.2 Biocoat Major Business
    • 2.4.3 Biocoat Medical Anti-Thrombotic Coating Product and Services
    • 2.4.4 Biocoat Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biocoat Recent Developments/Updates
  • 2.5 Coatings2Go
    • 2.5.1 Coatings2Go Details
    • 2.5.2 Coatings2Go Major Business
    • 2.5.3 Coatings2Go Medical Anti-Thrombotic Coating Product and Services
    • 2.5.4 Coatings2Go Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Coatings2Go Recent Developments/Updates
  • 2.6 Thermal Spray Technologies
    • 2.6.1 Thermal Spray Technologies Details
    • 2.6.2 Thermal Spray Technologies Major Business
    • 2.6.3 Thermal Spray Technologies Medical Anti-Thrombotic Coating Product and Services
    • 2.6.4 Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Thermal Spray Technologies Recent Developments/Updates
  • 2.7 Hydromer
    • 2.7.1 Hydromer Details
    • 2.7.2 Hydromer Major Business
    • 2.7.3 Hydromer Medical Anti-Thrombotic Coating Product and Services
    • 2.7.4 Hydromer Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hydromer Recent Developments/Updates
  • 2.8 Harland Medical Systems
    • 2.8.1 Harland Medical Systems Details
    • 2.8.2 Harland Medical Systems Major Business
    • 2.8.3 Harland Medical Systems Medical Anti-Thrombotic Coating Product and Services
    • 2.8.4 Harland Medical Systems Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Harland Medical Systems Recent Developments/Updates
  • 2.9 AST Products
    • 2.9.1 AST Products Details
    • 2.9.2 AST Products Major Business
    • 2.9.3 AST Products Medical Anti-Thrombotic Coating Product and Services
    • 2.9.4 AST Products Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AST Products Recent Developments/Updates
  • 2.10 Precision Coating
    • 2.10.1 Precision Coating Details
    • 2.10.2 Precision Coating Major Business
    • 2.10.3 Precision Coating Medical Anti-Thrombotic Coating Product and Services
    • 2.10.4 Precision Coating Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Precision Coating Recent Developments/Updates
  • 2.11 Surface Solutions Group
    • 2.11.1 Surface Solutions Group Details
    • 2.11.2 Surface Solutions Group Major Business
    • 2.11.3 Surface Solutions Group Medical Anti-Thrombotic Coating Product and Services
    • 2.11.4 Surface Solutions Group Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Surface Solutions Group Recent Developments/Updates
  • 2.12 ISurTec
    • 2.12.1 ISurTec Details
    • 2.12.2 ISurTec Major Business
    • 2.12.3 ISurTec Medical Anti-Thrombotic Coating Product and Services
    • 2.12.4 ISurTec Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 ISurTec Recent Developments/Updates
  • 2.13 Whitford
    • 2.13.1 Whitford Details
    • 2.13.2 Whitford Major Business
    • 2.13.3 Whitford Medical Anti-Thrombotic Coating Product and Services
    • 2.13.4 Whitford Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Whitford Recent Developments/Updates
  • 2.14 AdvanSource Biomaterials
    • 2.14.1 AdvanSource Biomaterials Details
    • 2.14.2 AdvanSource Biomaterials Major Business
    • 2.14.3 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product and Services
    • 2.14.4 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AdvanSource Biomaterials Recent Developments/Updates
  • 2.15 Jiangsu Biosurf Biotech
    • 2.15.1 Jiangsu Biosurf Biotech Details
    • 2.15.2 Jiangsu Biosurf Biotech Major Business
    • 2.15.3 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product and Services
    • 2.15.4 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Jiangsu Biosurf Biotech Recent Developments/Updates
  • 2.16 jMedtech
    • 2.16.1 jMedtech Details
    • 2.16.2 jMedtech Major Business
    • 2.16.3 jMedtech Medical Anti-Thrombotic Coating Product and Services
    • 2.16.4 jMedtech Medical Anti-Thrombotic Coating Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 jMedtech Recent Developments/Updates

3 Competitive Environment: Medical Anti-Thrombotic Coating by Manufacturer

  • 3.1 Global Medical Anti-Thrombotic Coating Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medical Anti-Thrombotic Coating Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medical Anti-Thrombotic Coating Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medical Anti-Thrombotic Coating by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medical Anti-Thrombotic Coating Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medical Anti-Thrombotic Coating Manufacturer Market Share in 2025
  • 3.5 Medical Anti-Thrombotic Coating Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Anti-Thrombotic Coating Market: Region Footprint
    • 3.5.2 Medical Anti-Thrombotic Coating Market: Company Product Type Footprint
    • 3.5.3 Medical Anti-Thrombotic Coating Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Anti-Thrombotic Coating Market Size by Region
    • 4.1.1 Global Medical Anti-Thrombotic Coating Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medical Anti-Thrombotic Coating Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medical Anti-Thrombotic Coating Average Price by Region (2021-2032)
  • 4.2 North America Medical Anti-Thrombotic Coating Consumption Value (2021-2032)
  • 4.3 Europe Medical Anti-Thrombotic Coating Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medical Anti-Thrombotic Coating Consumption Value (2021-2032)
  • 4.5 South America Medical Anti-Thrombotic Coating Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medical Anti-Thrombotic Coating Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 5.2 Global Medical Anti-Thrombotic Coating Consumption Value by Type (2021-2032)
  • 5.3 Global Medical Anti-Thrombotic Coating Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 6.2 Global Medical Anti-Thrombotic Coating Consumption Value by Application (2021-2032)
  • 6.3 Global Medical Anti-Thrombotic Coating Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 7.2 North America Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 7.3 North America Medical Anti-Thrombotic Coating Market Size by Country
    • 7.3.1 North America Medical Anti-Thrombotic Coating Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medical Anti-Thrombotic Coating Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medical Anti-Thrombotic Coating Market Size by Country
    • 8.3.1 Europe Medical Anti-Thrombotic Coating Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medical Anti-Thrombotic Coating Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medical Anti-Thrombotic Coating Market Size by Region
    • 9.3.1 Asia-Pacific Medical Anti-Thrombotic Coating Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medical Anti-Thrombotic Coating Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 10.2 South America Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 10.3 South America Medical Anti-Thrombotic Coating Market Size by Country
    • 10.3.1 South America Medical Anti-Thrombotic Coating Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medical Anti-Thrombotic Coating Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Anti-Thrombotic Coating Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medical Anti-Thrombotic Coating Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medical Anti-Thrombotic Coating Market Size by Country
    • 11.3.1 Middle East & Africa Medical Anti-Thrombotic Coating Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medical Anti-Thrombotic Coating Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medical Anti-Thrombotic Coating Market Drivers
  • 12.2 Medical Anti-Thrombotic Coating Market Restraints
  • 12.3 Medical Anti-Thrombotic Coating Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Anti-Thrombotic Coating and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Anti-Thrombotic Coating
  • 13.3 Medical Anti-Thrombotic Coating Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Anti-Thrombotic Coating Typical Distributors
  • 14.3 Medical Anti-Thrombotic Coating Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Medical Anti-Thrombotic Coating market size was valued at US$ 2202 million in 2025 and is forecast to a readjusted size of US$ 4290 million by 2032 with a CAGR of 10.0% during review period.
    In 2025, global Medical Anti-Thrombotic Coating production reached approximately 23.26 k tons, with an average global market price of around US$92,000 per ton.
    The gross profit margin of major companies in the industry is between 45%–65%.
    In 2025, the global production capacity of medical anti-thrombotic coating was approximately 31.01 k tons.
    Medical Anti-Thrombotic Coatings are specialized surface treatments applied to blood-contacting medical devices to reduce platelet adhesion, coagulation, and thrombus formation. These coatings typically utilize heparin-based, hydrophilic polymer, or bioactive formulations to improve hemocompatibility and device safety. They play a critical role in cardiovascular and interventional procedures by lowering the risk of clot-related complications and improving clinical outcomes.
    The industrial chain of Medical Anti-Thrombotic Coatings includes upstream bioactive agents, polymers, solvents, and surface modification materials. The midstream focuses on coating formulation, surface treatment processes, curing, and quality validation. Downstream applications cover catheters, guidewires, stents, vascular grafts, extracorporeal circulation devices, and implantable medical products, supported by regulatory compliance, validation testing, and technical services.
    The medical anti-thrombotic coating market is driven by the rapid growth of cardiovascular diseases, aging populations, and increasing use of minimally invasive medical devices. As interventional procedures expand, demand for improved blood compatibility and device safety continues to rise. Anti-thrombotic coatings help reduce procedural risks and improve long-term performance of implanted and disposable devices. Advances in polymer science and bioactive materials enable more durable and multifunctional coating solutions. Regulatory emphasis on patient safety further accelerates adoption. Overall, the market is expected to grow steadily as medical device innovation and clinical demand for safer blood-contacting devices continue to increase.
    This report is a detailed and comprehensive analysis for global Medical Anti-Thrombotic Coating market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Medical Anti-Thrombotic Coating market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
    Global Medical Anti-Thrombotic Coating market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
    Global Medical Anti-Thrombotic Coating market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2021-2032
    Global Medical Anti-Thrombotic Coating market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medical Anti-Thrombotic Coating
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medical Anti-Thrombotic Coating market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM Biomedical, Surmodics, Specialty Coating Systems (SCS), Biocoat, Coatings2Go, Thermal Spray Technologies, Hydromer, Harland Medical Systems, AST Products, Precision Coating, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Medical Anti-Thrombotic Coating market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Thin Coating
    Thick Coating
    Market segment by Coating Method
    Dip-Coated Anti-Thrombotic Layer
    Spray-Coated Anti-Thrombotic Layer
    Plasma-Deposited Coating
    Market segment by Durability Profile
    Short-Term Blood-Contact Coating
    Long-Term Implantable Coating
    Controlled-Degradation Coating
    Market segment by Application
    Catheter
    Stent Delivery System
    Guide Wire
    Others
    Major players covered
    DSM Biomedical
    Surmodics
    Specialty Coating Systems (SCS)
    Biocoat
    Coatings2Go
    Thermal Spray Technologies
    Hydromer
    Harland Medical Systems
    AST Products
    Precision Coating
    Surface Solutions Group
    ISurTec
    Whitford
    AdvanSource Biomaterials
    Jiangsu Biosurf Biotech
    jMedtech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Medical Anti-Thrombotic Coating product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Medical Anti-Thrombotic Coating, with price, sales quantity, revenue, and global market share of Medical Anti-Thrombotic Coating from 2021 to 2026.
    Chapter 3, the Medical Anti-Thrombotic Coating competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Medical Anti-Thrombotic Coating breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Anti-Thrombotic Coating market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Anti-Thrombotic Coating.
    Chapter 14 and 15, to describe Medical Anti-Thrombotic Coating sales channel, distributors, customers, research findings and conclusion.

    Buy now